Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN111087338B reveals a copper-catalyzed route for sulfonamide-substituted pyrrolidones, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN1076441A reveals a high-yield route for fibrinogen receptor antagonists, eliminating hazardous NaH/DMF steps and ensuring >99% purity for scalable API production.
Novel synthesis route for sodium valproate impurity K avoiding chromatography. High purity, scalable process for pharmaceutical intermediates.
Patent CN1235856C reveals a novel carbonylation route for phenylacetic acid derivatives, offering significant cost reduction and purity improvements for API manufacturing.
Patent CN108558776B reveals a green route replacing sulfuric acid with formic acid, enabling solvent recovery and waste reduction for reliable supply.
Patent CN102264715B reveals a scalable cinchonidine salt resolution process for HCV inhibitors, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel formate salt route for guanine intermediate reduces waste and improves yield for antiviral drug manufacturing supply chains globally ensuring regulatory compliance.
Patent CN104561136A enables high-yield chiral aryl ortho-diol production. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN1832931A reveals a safer process for phenyltetrazole intermediates. Discover cost reduction in pharma manufacturing and reliable supply chain solutions.
Novel manganese-catalyzed method improves yield and color. Reliable supplier for pharmaceutical intermediates manufacturing.
Novel water-phase synthesis reduces waste and cost for API manufacturing. High purity tetrazoleacetic acid available for commercial scale-up.
Advanced synthesis of PDE IV inhibitor intermediates via lithium bromide-mediated hydrolysis. Enhanced purity and streamlined manufacturing for pharmaceutical supply chains.
Patent CN118638088B enables green flavonoid production. Reduces toxicity and cost. Reliable supply chain for pharmaceutical intermediates.
Patent CN105327703A details a recyclable gold nanocatalyst for quinazoline synthesis. This method eliminates hazardous oxidants, offering safer supply chains and cost-effective manufacturing for pharmaceutical intermediates.
Optimized sildenafil citrate synthesis via patent CN103613597A. Delivers high purity, cost efficiency, and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN114874134A details a protection-free asymmetric synthesis of nicotine using Ir-catalysis, offering high ee values and scalable manufacturing for pharmaceutical intermediates.
Novel urea compound for diabetes research. Optimized synthesis route ensures supply continuity and cost efficiency for global pharmaceutical partners seeking reliable intermediates.
Novel enzymatic route for dabigatran intermediate offers high purity and cost efficiency for pharmaceutical manufacturing supply chains globally ensuring reliable production capacity.
Novel photocatalytic route for Zolpidem reduces steps and toxicity. Offers supply chain stability and cost efficiency for pharmaceutical manufacturers globally.
Patent CN118516426A reveals enzymatic route for chiral intermediates. High purity, mild conditions, cost-effective for pharma supply chains.